ELEV - What's Going On With Elevation Oncology Stock? | Benzinga
Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday. Here's a look at what's going on.
The Details:
Elevation Oncology said that it plans to provide an update from its ongoing Phase 1 trial of EO-3021 in mid-2024, with additional data expected in the first half of 2025.
The company also plans to expand its ...